Related Experiment Video
Updated: Jun 13, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Receptor and cell-type-specific mechanisms in mesocortical dopamine circuits gate chronic pain and comorbid
Ya-Qi Cai1, Xin-Yu Hou1, Guo-Hong Wang1
1Department of Translational Neuroscience, Jing'an District Centre Hospital of Shanghai, State Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai 200032, China.
Abstract:
The mesocorticolimbic dopamine (DA) circuitry is implicated in chronic pain and comorbid depression, yet the specific receptor and circuit mechanisms distinguishing them remain unclear. Here, we show that orbitofrontal cortex (OFC) D1R- and D2R-expressing neurons serve as a checkpoint, independently mediating anxiodepression and allodynia in a trigeminal neuralgia (TN) mouse model. TN induced a hypodopaminergic state in the ventral tegmental area (VTA)-OFC circuit. Activation of the VTADA-OFC pathway effectively ameliorated TN-induced allodynia and anxiodepressive-like behaviors; these therapeutic effects were abolished by selective blockade of D2Rs and D1Rs, respectively. Activation of OFCD1 excitatory pyramidal neurons and their projections to the laterodorsal tegmental nucleus (LDTg) improved TN-induced anxiodepressive-like behaviors, whereas disinhibition or activation of OFC D2+ excitatory pyramidal neurons and their projections to the basolateral amygdaloid nucleus (BLA) produced analgesia. Thus, selectively targeting VTA-OFCD1 and VTA-OFCD2 or OFC D1Rs and D2Rs may provide new strategies for controlling different symptoms of chronic pain.
Insights
The mesocorticolimbic dopamine circuitry in the brain plays a role in chronic pain and depression. Targeting specific dopamine receptors (D1R and D2R) in the orbitofrontal cortex may offer new pain and depression treatment strategies.
Area of Science:
- Neuroscience
- Pain Research
- Dopamine Signaling
Background:
- The mesocorticolimbic dopamine (DA) system is linked to chronic pain and depression.
- Specific receptor and circuit mechanisms underlying these conditions are not fully understood.
Purpose of the Study:
- To investigate the role of orbitofrontal cortex (OFC) dopamine receptors (D1R and D2R) in mediating pain and depressive behaviors.
- To explore the therapeutic potential of targeting the ventral tegmental area (VTA)-OFC pathway in a trigeminal neuralgia (TN) mouse model.
Main Methods:
- Utilized a trigeminal neuralgia (TN) mouse model.
- Investigated the effects of activating or blocking dopamine receptors (D1R, D2R) in the OFC.
- Examined neuronal projections from the OFC to the laterodorsal tegmental nucleus (LDTg) and basolateral amygdaloid nucleus (BLA).
Main Results:
- TN induced a hypodopaminergic state in the VTA-OFC circuit.
- Activation of the VTA-DA-OFC pathway reduced both allodynia and anxiodepressive-like behaviors.
- Selective blockade of D2Rs abolished pain relief, while D1R blockade abolished depression relief.
- Targeting OFC D1R+ neurons improved depressive behaviors; targeting OFC D2+ neurons produced analgesia.
Conclusions:
- OFC D1R- and D2R-expressing neurons independently mediate anxiodepression and allodynia.
- Selective modulation of VTA-OFC dopamine pathways offers potential therapeutic strategies for distinct chronic pain symptoms.
Related Concept Videos
Analgesia and Pain Management
Opioid Receptors: Overview
G-protein Coupled Receptors
Pain
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Nociception
